Funding for Medical Research
and Clinical Trials
and Clinical Trials
Funding Details for Cancer
Use the contact information shown for the organization to apply for the funding.
Please notify CenTrial of any offer is incorrect or has expired.
Please notify CenTrial of any offer is incorrect or has expired.
Leukemia & Lymphoma
Leukemia & Lymphoma Society
Type of Organization: Foundation
Email Address: researchprograms@lls.org
Funds Available for Clinical Trials: ✗ Research: ✔
The Blood Cancer Discoveries Grant Program (BCDG) is now simply called Discovery Grant Program (DGP). This name change will only affect grantees activated after October 1, 2023
The applicant (PI) must be an established investigator, defined as a researcher with more than 3 years in an independent faculty appointment at the time of submitting the Letter of Intent
Other info: The Leukemia & Lymphoma Society (LLS) is proud to announce the Discovery Grant Program (DGP): a research award program designed to encourage basic research, technological innovation, and informatics pipeline development that can lead to an understanding of blood cancer disease mechanisms, the development of improved methods for detecting and monitoring cancer progression, and the identification of novel therapeutic targets. This is a dedicated mechanism to encourage established investigators to explore the biology of blood cancer and support proof-of-concept studies that could initiate completely novel approaches to treatment.
Applications for 2024-2025 opens in Fall.
Leukemia & Lymphoma Society
Type of Organization: Foundation
Email Address: researchprograms@lls.org
Funds Available for Clinical Trials: ✗ Research: ✔
Funding Details
Requirements: If you currently hold a Discovery Grant Program (DGP) or Blood Cancer Discoveries Grant Program (BCDG) award, you may not apply to DGP in this cycle unless your current award is scheduled to end before October 1, 2024.The Blood Cancer Discoveries Grant Program (BCDG) is now simply called Discovery Grant Program (DGP). This name change will only affect grantees activated after October 1, 2023
The applicant (PI) must be an established investigator, defined as a researcher with more than 3 years in an independent faculty appointment at the time of submitting the Letter of Intent
Other info: The Leukemia & Lymphoma Society (LLS) is proud to announce the Discovery Grant Program (DGP): a research award program designed to encourage basic research, technological innovation, and informatics pipeline development that can lead to an understanding of blood cancer disease mechanisms, the development of improved methods for detecting and monitoring cancer progression, and the identification of novel therapeutic targets. This is a dedicated mechanism to encourage established investigators to explore the biology of blood cancer and support proof-of-concept studies that could initiate completely novel approaches to treatment.
Applications for 2024-2025 opens in Fall.